Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001683168-18-003679
Filing Date
2018-12-12
Accepted
2018-12-12 16:58:02
Documents
39
Period of Report
2018-07-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K odyssey_10k-073118.htm 10-K 350112
2 CERTIFICATION odyssey_10k-ex3101.htm EX-31.1 7391
3 CERTIFICATION odyssey_10k-ex3201.htm EX-32.1 3199
4 GRAPHIC image_001.jpg GRAPHIC 10279
5 GRAPHIC image_002.jpg GRAPHIC 3683
  Complete submission text file 0001683168-18-003679.txt   1111228

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE odyy-20180731.xml EX-101.INS 62835
7 XBRL SCHEMA FILE odyy-20180731.xsd EX-101.SCH 14687
8 XBRL CALCULATION FILE odyy-20180731_cal.xml EX-101.CAL 25221
9 XBRL DEFINITION FILE odyy-20180731_def.xml EX-101.DEF 28245
10 XBRL LABEL FILE odyy-20180731_lab.xml EX-101.LAB 98426
11 XBRL PRESENTATION FILE odyy-20180731_pre.xml EX-101.PRE 78179
Mailing Address 4262 BLUE DIAMOND ROAD, SUITE 102-281 LAS VEGAS NV 89139
Business Address 4262 BLUE DIAMOND ROAD, SUITE 102-281 LAS VEGAS NV 89139 702-751-1418
Odyssey Group International, Inc. (Filer) CIK: 0001626644 (see all company filings)

EIN.: 471022125 | State of Incorp.: NV | Fiscal Year End: 0731
Type: 10-K | Act: 34 | File No.: 333-200785 | Film No.: 181231371
SIC: 2833 Medicinal Chemicals & Botanical Products